Evidence map›Paper›PMID 30926303›Full record

ArticleThe Lancet. Global health2019

Geographical distribution and prevalence of podoconiosis in Rwanda: a cross-sectional country-wide survey.

Kebede Deribe, Aimable Mbituyumuremyi, Jorge Cano, Mbonigaba Jean Bosco, Emanuele Giorgi, Eugene Ruberanziza, Ursin Bayisenge, Uwayezu Leonard, Jean Paul Bikorimana, Aniceth Rucogoza and 12 more

Open access · goldAbstract read
In one paragraph

Article in The Lancet. Global health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 3 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 3 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Podoconiosis in Uganda: prevalence, geographical distribution and risk factors.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Geostatistical modelling of the distribution, risk and burden of podoconiosis in Kenya.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 10 institutions in 5 countries.

Kebede DeribeWellcome Trust Brighton and Sussex Centre for Global Health Research, Brighton and Sussex Medical School, Brighton, UK; School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia. Electronic address: k.deribe@bsms.ac.uk.
Aimable MbituyumuremyiMalaria and Other Parasitic Disease Division, Rwanda Biomedical Center-Ministry of Health, Kigali, Rwanda.
Jorge CanoDepartment of Disease Control, London School of Hygiene & Tropical Medicine, London, UK.
Mbonigaba Jean BoscoMalaria and Other Parasitic Disease Division, Rwanda Biomedical Center-Ministry of Health, Kigali, Rwanda.
Emanuele GiorgiDepartment of Disease Control, London School of Hygiene & Tropical Medicine, London, UK; Lancaster Medical School, Faculty of Health and Medicine, Lancaster University, Lancaster, UK.
Eugene RuberanzizaMalaria and Other Parasitic Disease Division, Rwanda Biomedical Center-Ministry of Health, Kigali, Rwanda.
Ursin BayisengeMalaria and Other Parasitic Disease Division, Rwanda Biomedical Center-Ministry of Health, Kigali, Rwanda.
Uwayezu LeonardByumba Hospital, Kibali, Rwanda.
Jean Paul BikorimanaHeart and Sole Africa in Ruhengeri, Musanze, Rwanda.
Aniceth RucogozaNational Reference Laboratory, Rwanda Biomedical Center, Kigali, Rwanda.
Innocent TurateInstitute of HIV/AIDS, Disease Control and Prevention Department, Rwanda Biomedical Center, Kigali, Rwanda.
Andre RusanganwaWorld Health Organization, Rwanda Country Office, Kigali, Rwanda.
David M PigottInstitute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Rachel L PullanDepartment of Disease Control, London School of Hygiene & Tropical Medicine, London, UK.
Abdisalan M NoorKenya Medical Research Institute-Wellcome Trust Collaborative Programme, Nairobi, Kenya; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, UK.
Fikre EnquselassieSchool of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.
Jeanine U CondoMalaria and Other Parasitic Disease Division, Rwanda Biomedical Center-Ministry of Health, Kigali, Rwanda.
Christopher J L MurrayInstitute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Simon J BrookerBill & Melinda Gates Foundation, Seattle, WA, USA.
Simon I HayInstitute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Melanie J NewportWellcome Trust Brighton and Sussex Centre for Global Health Research, Brighton and Sussex Medical School, Brighton, UK.
Gail DaveyWellcome Trust Brighton and Sussex Centre for Global Health Research, Brighton and Sussex Medical School, Brighton, UK; School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.
Rwanda Biomedical Center · RWLondon School of Hygiene & Tropical Medicine · GBAddis Ababa University · ETInstitute for Health Metrics and Evaluation · USMinistry of Health · RWWellcome Trust · GBBill & Melinda Gates Foundation · USRwanda Military Hospital · RWUniversity of Oxford · GBUniversity of Washington · US

Funding

Wellcome Trust 201900Wellcome Trust 201900/Z/16/ZWorld Health Organization 001
6 · The paper itself

Abstract

backgroundPodoconiosis is a type of tropical lymphoedema that causes massive swelling of the lower limbs. The disease is associated with both economic insecurity, due to long-term morbidity-related loss of productivity, and intense social stigma. Reliable and detailed data on the prevalence and distribution of podoconiosis are scarce. We aimed to fill this data gap by doing a nationwide community-based study to estimate the number of cases throughout Rwanda.

methodsWe did a population-based cross-sectional survey to determine the national prevalence of podoconiosis. A podoconiosis case was defined as a person with bilateral, asymmetrical lymphoedema of the lower limb present for more than 1 year, who tested negative for Wuchereria bancrofti antigen (determined by Filariasis Test Strip) and specific IgG4 (determined by Wb123 test), and had a history of any of the associated clinical signs and symptoms. All adults (aged ≥15 years) who resided in any of the 30 districts of Rwanda for 10 or more years were invited at the household level to participate. Participants were interviewed and given a physical examination before Filariasis Test Strip and Wb123 testing. We fitted a binomial mixed model combining the site-level podoconiosis prevalence with continuous environmental covariates to estimate prevalence at unsampled locations. We report estimates of cases by district combining our mean predicted prevalence and a contemporary gridded map of estimated population density.

findingsBetween June 12, and July 28, 2017, 1 360 612 individuals-719 730 (53%) women and 640 882 (47%) men-were screened from 80 clusters in 30 districts across Rwanda. 1143 individuals with lymphoedema were identified, of whom 914 (80%) had confirmed podoconiosis, based on the standardised diagnostic algorithm. The overall prevalence of podoconiosis was 68·5 per 100 000 people (95% CI 41·0-109·7). Podoconiosis was found to be widespread in Rwanda. District-level prevalence ranged from 28·3 per 100 000 people (16·8-45·5, Nyarugenge, Kigali province) to 119·2 per 100 000 people (59·9-216·2, Nyamasheke, West province). Prevalence was highest in districts in the North and West provinces: Nyamasheke, Rusizi, Musanze, Nyabihu, Nyaruguru, Burera, and Rubavu. We estimate that 6429 (95% CI 3938-10 088) people live with podoconiosis across Rwanda.

interpretationDespite relatively low prevalence, podoconiosis is widely distributed geographically throughout Rwanda. Many patients are likely to be undiagnosed and morbidity management is scarce. Targeted interventions through a well coordinated health system response are needed to manage those affected. Our findings should inform national level planning, monitoring, and implementation of interventions.

fundingWellcome Trust.

Indexed as

AdolescentAdultAgedAged, 80 and overAge FactorsCross-Sectional StudiesEducational StatusElephantiasisFemaleGeographyHumansMaleMiddle AgedPrevalenceRisk FactorsRwanda

Identifiers

PMID30926303
PMCPMC6465958
OpenAlexW2925271122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.